Since DCs usually confer protection against pathogens and disease, they are critical mediators of anti-tumor immunity and can be pulsed with peptide epitopes of tumor antigens to prime CD8+ T cells for an anti-tumor response (94). This evidence concerns the gene CD8A and neoplasm.